Valuation: Harbin Gloria Pharmaceuticals Co., Ltd

Market Cap 642.2Cr 95Cr 83Cr 77Cr 71Cr 133.24Cr 9.09TCr 136.62Cr 914.89Cr 357.54Cr 4.5TCr 356.96Cr 349.19Cr 16TCr P/E 2024
24.2x
P/E 2025 18.2x
Enterprise Value 558.4Cr 83Cr 72Cr 67Cr 62Cr 115.85Cr 7.91TCr 118.79Cr 795.5Cr 310.88Cr 3.92TCr 310.37Cr 303.62Cr 14TCr EV / Sales 2024
2.12x
EV / Sales 2025 2.82x
Free-Float
90.63%
Yield 2024 *
-
Yield 2025 -
1 week+1.77%
Current month+6.67%
1 month+18.52%
3 months-20.22%
6 months-17.48%
Current year-6.19%
1 week 2.72
Extreme 2.72
2.97
1 month 2.62
Extreme 2.62
3.24
Current year 2.37
Extreme 2.37
3.99
1 year 2.37
Extreme 2.37
4.08
3 years 1.66
Extreme 1.66
4.08
5 years 1.66
Extreme 1.66
4.08
10 years 1.66
Extreme 1.66
9.8
Manager TitleAgeSince
Chief Executive Officer 53 26/12/2022
Corporate Officer/Principal 42 18/04/2018
Corporate Officer/Principal 40 23/05/2019
Director TitleAgeSince
Director/Board Member 40 14/03/2025
Director/Board Member 53 11/11/2022
Director/Board Member 42 11/11/2022
Date Insider Type Main position Quantity % Market Cap.
02/07/25 Sell 5,87,500 0.0283%
02/07/25 Sell

Director

2,59,600 0.0125%
02/07/25 Sell 5,87,500 0.0283%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.77%-15.29%+30.91% 95Cr
+0.67%+1.43%+16.90%+74.77% 4.96TCr
+1.05%+3.84%+64.12%+113.57% 3.65TCr
+2.06%+2.92%-6.22%+25.17% 1.22TCr
+2.14%-1.78%+14.55%+75.28% 1.15TCr
+0.19%+1.35%+31.58%+132.30% 903.89Cr
+3.08%+3.94%+50.54%-4.41% 693.82Cr
+0.17%-0.68%+11.96%+33.49% 673.8Cr
+3.53%+0.87%+5.47%+183.15% 645.3Cr
+0.61%-6.24%-32.70%-1.66% 541.53Cr
Average +1.35%-0.65%+14.09%+66.26% 1.45TCr
Weighted average by Cap. +1.18%+0.44%+26.36%+79.96%

Financials

2024 2025
Net sales 244.07Cr 36Cr 31Cr 29Cr 27Cr 51Cr 3.46TCr 52Cr 347.71Cr 135.88Cr 1.71TCr 135.66Cr 132.71Cr 5.9TCr 213.55Cr 32Cr 28Cr 26Cr 24Cr 44Cr 3.02TCr 45Cr 304.22Cr 118.89Cr 1.5TCr 118.69Cr 116.11Cr 5.16TCr
Net income 23Cr 3.45Cr 3Cr 2.8Cr 2.57Cr 4.83Cr 329.57Cr 4.95Cr 33Cr 13Cr 163.21Cr 13Cr 13Cr 562.95Cr 38Cr 5.58Cr 4.86Cr 4.53Cr 4.16Cr 7.82Cr 533.67Cr 8.02Cr 54Cr 21Cr 264.28Cr 21Cr 20Cr 911.58Cr
Net Debt -51Cr -7.53Cr -6.55Cr -6.12Cr -5.62Cr -11Cr -720.26Cr -11Cr -72Cr -28Cr -356.68Cr -28Cr -28Cr -1.23TCr -84Cr -12Cr -11Cr -10Cr -9.26Cr -17Cr -1.19TCr -18Cr -119.39Cr -47Cr -587.63Cr -47Cr -46Cr -2.03TCr
Logo Harbin Gloria Pharmaceuticals Co., Ltd
HARBIN GLORIA PHARMACEUTICALS Co Ltd is a China-based company principally engaged in the research, development, production and sale of pharmaceuticals. The Company operates its businesses through three segments. The Traditional Chinese Medicine segment's main product is Annao Pills and Tablets. The Chemical Pharmaceuticals segment's products include cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamins, electrolytes, analgesics, anti-infectives, anti-tumor drugs and others. The Others segment engages in pharmaceutical research and development, clinical services and others. The Company distributes its products within the domestic market and to overseas markets.
Employees
2,350
Date Price Change Volume
29/26/29 CN¥2.880 0.00% 6,42,79,275
28/26/28 CN¥2.880 -0.69% 6,58,53,700
27/26/27 CN¥2.900 +5.07% 7,54,86,400
24/26/24 CN¥2.760 -3.83% 5,72,91,307
23/26/23 CN¥2.870 +1.41% 7,26,17,049

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002437 Stock